-
The winners of Fast Company’s 2021 World Changing Ideas Awards were announced today, honoring the businesses, policies, projects, and concepts that are actively engaged and deeply committed to pursuing innovation when it comes to solving health and climate crises, social injustice, or economic inequality. SingleStore, the unified database for fast analytics, received an honorable mention in the AI and data category for its work with Thorn, which uses SingleStore to leverage data to find traffick
-
Nexus Pharmaceuticals Inc., a US-based healthcare company and domestic manufacturer, today announced that they transported via a special air freight charter through DB Schenker 82 tons of vaccine filling equipment, including a vaccine filling machine and isolator from Bausch + Stroebel and Franz Ziel. Once the production line is operational, Nexus will have the capability to produce up to 30 million doses of vaccines per month. This press release features multimedia. View the full release here:
-
Why Workplace Accessibility Matters: Hear From Persons With Disabilities Succeeding at Work Thu, 09/10/2020 - 16:05 Subheader Insights from Accenture colleagues on accessibility when you walk in the shoes of someone who is deaf, blind or autistic. Type of Content Blog Layout Featured Media Body Imagine a world that is: Silent. Dark. Confusing. Out of reach. Walk in the shoes of someone who is deaf, blind, autistic or in a wheelchair, and the world will appear very different. Perhaps even isolati
-
Ideagen TV Presents a New Series With Mary Millben, Award Winning Singer, Actress Songwriter Thu, 06/18/2020 - 17:15 Subheader Ideagen TV "Where Global Leaders Convene" Presents, "Impact Now" with Mary Millben Type of Content Multimedia with summary Layout Featured Media Body WASHINGTON, D.C., June 18, 2020 /3BL Media/ - Ideagen® - “Where Global Leaders Convene” Ideagen® is dedicated to providing a global platform to foster cross-sector collaboration by the world’s leading Brands, Companies, NG
-
Goodbye Fibroids aims to empower women to raise their voices, get the
treatment they want, and elevate the standard of care for uterine
fibroids.